Literature DB >> 27822430

GPX3 hypermethylation serves as an independent prognostic biomarker in non-M3 acute myeloid leukemia [Retraction].

.   

Abstract

[This retracts the article on p. 2047 in vol. 5, PMID: 26269763.].

Entities:  

Year:  2016        PMID： 27822430      PMCID： PMC5088304     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN： 2156-6976            Impact factor:   6.166


  1 in total

1.  GPX3 methylation is associated with hematologic improvement in low-risk myelodysplastic syndrome patients treated with Pai-Neng-Da.

Authors:  Shujun Yang; Tong Gao; Zhonghua Zheng; Binbin Lai; Lixia Sheng; Zhijuan Xu; Xiao Yan; Jiaping Wang; Shiwei Duan; Guifang Ouyang
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.